107 related articles for article (PubMed ID: 8027973)
1. Derivatives of a novel cyclopeptolide. 2. Synthesis, activity against multidrug resistance in CHO and KB cells in vitro, and structure-activity relationships.
Emmer G; Grassberger MA; Schulz G; Boesch D; Gavériaux C; Loor F
J Med Chem; 1994 Jun; 37(13):1918-28. PubMed ID: 8027973
[TBL] [Abstract][Full Text] [Related]
2. SDZ 280-125: a cyclopeptolide endowed with an in vitro cyclosporin A-like profile of activity for the reversion of the P-glycoprotein-mediated multidrug resistance of tumor cells.
Jachez B; Boesch D; Emmer G; Loor F
Anticancer Drugs; 1994 Jun; 5(3):313-20. PubMed ID: 7919456
[TBL] [Abstract][Full Text] [Related]
3. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
Jachez B; Nordmann R; Loor F
J Natl Cancer Inst; 1993 Mar; 85(6):478-83. PubMed ID: 8095304
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of a novel cyclopeptolide. 1. Synthesis, antifungal activity, and structure-activity relationships.
Emmer G; Grassberger MA; Meingassner JG; Schulz G; Schaude M
J Med Chem; 1994 Jun; 37(13):1908-17. PubMed ID: 8027972
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytostatic activities of didemnin derivatives.
Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
[TBL] [Abstract][Full Text] [Related]
6. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
[TBL] [Abstract][Full Text] [Related]
7. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.
Guan J; Zhu XK; Tachibana Y; Bastow KF; Brossi A; Hamel E; Lee KH
J Med Chem; 1998 May; 41(11):1956-61. PubMed ID: 9599244
[TBL] [Abstract][Full Text] [Related]
11. Studies on RA derivatives. V. Synthesis and antitumor activity of Ala2-modified RA-VII derivatives.
Itokawa H; Kondo K; Hitotsuyanagi Y; Isomura M; Takeya K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1402-10. PubMed ID: 8403089
[TBL] [Abstract][Full Text] [Related]
12. Improved total synthesis and structure-activity relationship of arenastatin A, a potent cytotoxic spongean depsipeptide.
Kobayashi M; Wang W; Ohyabu N; Kurosu M; Kitagawa I
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1598-600. PubMed ID: 7586087
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis of [(2S)-Hiv2]didemnin M.
Liang B; Vera MD; Joullié MM
J Org Chem; 2000 Jul; 65(15):4762-5. PubMed ID: 10959892
[No Abstract] [Full Text] [Related]
15. New synthetic thiocolchicine derivatives as lowtoxic anticancer agents.
Lee SH; Park SK; Kim JM; Kim MH; Kim KH; Chun KW; Cho KH; Youn JY; Namgoong SK
Arch Pharm (Weinheim); 2005 Dec; 338(12):582-9. PubMed ID: 16353277
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives.
Jung JC; Lee JH; Oh S; Lee JG; Park OS
Bioorg Med Chem Lett; 2004 Nov; 14(22):5527-31. PubMed ID: 15482917
[TBL] [Abstract][Full Text] [Related]
17. Structure--activity relationships of side-chain modified didemnins.
Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
